Text Size

Overnight Post-Exercise Recovery After Protein Ingestion Prior to Sleep

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00991523
First received: October 6, 2009
Last updated: April 19, 2011
Last verified: April 2011
History of Changes
  Purpose

The purpose of this study is to examine the effects of post-exercise protein ingestion prior to sleep on overnight protein kinetics and muscle recovery.


Condition Intervention
Exercise
Resistance Training
 Dietary Supplement: protein
Dietary Supplement: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Protein Ingestion Prior to Sleep as a Dietary Strategy to Improve Post-exercise, Overnight Recovery.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Maastricht University Medical Center:

Primary Outcome Measures:
  • muscle protein synthesis [ Time Frame: 10 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 24
Study Start Date: October 2009
Study Completion Date: December 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: sweetened beverage Dietary Supplement: protein
protein
Placebo Comparator: placebo control
placebo
 Dietary Supplement: placebo
placebo control

  Eligibility

Ages Eligible for Study:   20 Years to 30 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male
  • Age between 20 and 30 years
  • Healthy, recreationally active
  • BMI <25 kg/m2

Exclusion Criteria:

  • Use of medication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00991523

Locations
Netherlands
Maastricht MUMC
Maastricht, LI, Netherlands, 6202
MaastrichtUMC
Maastricht, Netherlands
Sponsors and Collaborators
Maastricht University Medical Center
GlaxoSmithKline
Investigators
Principal Investigator: Luc van Loon, PhD Maastricht University Medical Center
  More Information

No publications provided by Maastricht University Medical Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Luc van Loon, University Hospital Maastricht
ClinicalTrials.gov Identifier: NCT00991523     History of Changes
Other Study ID Numbers: MEC 09-3-054
Study First Received: October 6, 2009
Last Updated: April 19, 2011
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Maastricht University Medical Center:
resistance
exercise
protein
recovery

ClinicalTrials.gov processed this record on May 23, 2013